Synthetic Biologics to Report First Quarter 2014 Financial Results

[PR Newswire] – ROCKVILLE, Md., May 9, 2014 /PRNewswire/ — Synthetic Biologics, Inc. (NYSE MKT: SYN), a developer of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections … more

View todays social media effects on SYN

View the latest stocks trending across Twitter. Click to view dashboard

See who Synthetic is hiring next, click here to view